Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Weiming Duan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3771-1212; OpenAlex author ID A5068487074. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 6

  1. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer. Co-author DOI 10.1111/jcmm.17191↗
  2. Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis. Last author DOI 10.21037/tcr-20-2531↗
  3. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Co-author DOI 10.18632/oncotarget.9975↗
  4. FH535 inhibited metastasis and growth of pancreatic cancer cells. Co-author DOI 10.2147/ott.s82718↗
  5. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling… Co-author DOI 10.3892/ol.2014.2711↗
  6. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwa… Co-author DOI 10.1016/j.ejca.2011.08.014↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meng Shen · 3 shared papers, 2015–2022 · strength 0.25
  2. Mengyao Wu · 3 shared papers, 2015–2022 · strength 0.24
  3. Yi Yang · 1 shared paper, 2021 · strength 0.19
  4. Yujie Lu · 1 shared paper, 2021 · strength 0.19
  5. Min Tao · 4 shared papers, 2011–2016 · strength 0.17
  6. Zhan‐Wen Liang · 1 shared paper, 2022 · strength 0.15
  7. Mengdan Xu · 1 shared paper, 2022 · strength 0.15
  8. Wei Li · 1 shared paper, 2022 · strength 0.15
  9. Kai Chen · 3 shared papers, 2011–2016 · strength 0.12
  10. Daoming Li · 3 shared papers, 2011–2015 · strength 0.11
  11. Wei Li · 2 shared papers, 2015–2016 · strength 0.10
  12. Lian Lian · 2 shared papers, 2015–2016 · strength 0.10
  13. Lu Liu · 1 shared paper, 2016 · strength 0.05
  14. Mengyao Wu · 1 shared paper, 2016 · strength 0.05
  15. Qiaoming Zhi · 1 shared paper, 2016 · strength 0.05
  16. Yixiang Mao · 1 shared paper, 2015 · strength 0.05
  17. Xin Xie · 1 shared paper, 2015 · strength 0.05
  18. Zekuan Xu · 1 shared paper, 2011 · strength 0.02
  19. Wei Li · 1 shared paper, 2011 · strength 0.02
  20. Zheng Chen · 1 shared paper, 2011 · strength 0.02
  21. Yi Miao · 1 shared paper, 2011 · strength 0.02
  22. Xiao Han · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.